Omnicell Inc reports results for the quarter ended June 30 - Earnings Summary

Omnicell

30/07/2026 14:32

Omnicell Inc OMCL.OQ reported quarterly adjusted earnings of 94 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 45 cents.  The mean expectation of eight analysts for the quarter was for earnings of 47 cents per share. Wall Street expected results to range from 44 cents to 48 cents per share.
Revenue rose 7.4% to $312.21 million from a year ago; analysts expected $310.25 million. 
Omnicell Inc's reported EPS for the quarter was 52 cents​.
The company reported quarterly net income of $24.29 million.
Omnicell Inc shares had fallen by 0.3% this quarter and lost 8.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for Omnicell Inc is $60.00, about 31% above its last closing price of $41.40
This summary was machine generated from LSEG data July 30 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.47
0.94
Beat
Mar. 31 2026 
0.33
0.55
Beat
Dec. 31 2025 
0.50
0.40
Missed
Sep. 30 2025 
0.36
0.51
Beat